Anti-inflammatory and pro-angiogenic effects of beta blockers in a canine model of chronic ischemic cardiomyopathy: Comparison between carvedilol and metoprolol

Basic Research in Cardiology

Volumn 108, Issue 6, 2013, Pages

  Le, D Elizabeth ^a,f   Pascotto, Marco ^b   Leong Poi, Howard ^c,g   Sari, Ibrahim ^d,h   Micari, Antonio ^e,i   Kaul, Sanjiv ^f  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b Ospedale Buonconsiglio Fatebenefratelli   (Italy)

^c HEART AND STROKE FOUNDATION OF CANADA   (Canada)

^d Turkish Osteoporosis Society   (Turkey)

^e Italian Society of Cardiology Aventis Foundation   (Italy)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g ST MICHAEL'S HOSPITAL   (Canada)

^h GAZIANTEP UNIVERSITY   (Turkey)

ⁱ Research Ettore Sansavini Health Science Foundation   (Italy)

Author keywords

Angiogenesis; Beta blockers; Cytokines; Ischemic cardiomyopathy; Regional flow; Regional function

Indexed keywords

CARVEDILOL; CYTOKINE; INTERLEUKIN 10; METOPROLOL; PLACEBO;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AORTA PRESSURE; CAPILLARY DENSITY; CHRONIC DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DOG; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE WALL; HEART MUSCLE BLOOD FLOW; HEART RATE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTERSTITIAL FLUID; ISCHEMIC CARDIOMYOPATHY; LEUKOCYTE COUNT; LEUKOCYTOSIS; NONHUMAN; OXIDATIVE STRESS; RESTING HEART RATE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; WALL STRESS;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARBAZOLES; DOGS; ECHOCARDIOGRAPHY; HEART; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; METOPROLOL; MYOCARDIAL ISCHEMIA; OXIDATIVE STRESS; PROPANOLAMINES;

EID: 84890309223     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-013-0384-7     Document Type: Conference Paper

References (43)

1. Abbate A, Van Tassell BW, Seropian IM, Toldo S, Robati R, Varma A, Salloum FN, Smithson L, Dinarello CA (2010) Interleukin-1 modulation using a genetically engineered antibody prevents adverse cardiac remodeling following acute myocardial infarction in the mouse. Eur J Heart Fail 12:319-322. doi: 10.1093/eurjhf/hfq017
2. Bin JP, Wei K, Pelberg RA, Coggins M, Goodman NC, Kaul S (2000) Relation between regional function and coronary blood flow reserve in multivessel coronary artery stenosis. Am J Physiol 279:H3058-H3064
3. Bin JP, Pelberg RA, Coggins MP, Wei K, Kaul S (2002) Mechanism of Inducible regional dysfunction during dipyridamole Stress. Circulation 106:112-117. doi: 10.1161/01.CIR00000202230839005 (Pubitemid 34747450)
4. Brandtzaeg P, Osnes L, Ovstebo R, Joo GB, Westvik AB, Kierulf P (1996) Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes. J Exp Med 184:51-60. doi: 10.1084/jem.184.1.51 (Pubitemid 26247214)
5. Braunwald E, Kloner RA (1982) The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 66:1146-1149. doi: 10.1161/01.CIR.66.6.1146 (Pubitemid 13238825)
6. Braunwald E, Rutherford JD (1986) Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium". J Am Coll Cardiol 8:1467-1470. doi: 10.1016/S0735-1097(86)80325-4 (Pubitemid 17208930)
7. Bristow MR, Adams KF, Bauman JL, Feldman AM, Giles TD, Goldstein S, Mann DL, Talbert RL (2005) The COMET trial. Congest Heart Fail 11:39-47. doi: 10.1111/j.1527-5299.2005.04076.x
8. Camici PG, Wijns W, Borgers M, De Silva R, Ferrari J, Knuuti J, Lammerstma AA, Liedtke AJ, Paternostro G, Vatner SF (1997) Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation 96:3205-3214. doi: 10.1161/01.CIR.96.9.3205 (Pubitemid 27500127)
9. Castro P, Vukasovic JL, Chiong M, Diaz-Araya G, Alcaino H, Copaja M, Valenzuela R, Greig D, Perez O, Corbalan R, Lavandero S (2005) Effects of carvedilol on oxidative stress and chronotropic response to exercise in patients with chronic heart failure. Eur J Heart Fail 7:1033-1039. doi: 10.1016/j.ejheart.2004.11.009 (Pubitemid 41443599)
10. Clarke CJ, Hales A, Hunt A, Foxwell BM (1998) IL-10 mediated suppression of TNF-a production is independent of its ability to inhibit NF-kB activity. Eur J Immunol 28:1719-1726. doi: 10.1002/(SICI)1521-4141(199805)28:05<1719:AID- IMMU1719>3.0.CO;2-Q (Pubitemid 28221177)
11. Firoozan S, Wei K, Linka A, Skyba D, Goodman NC, Kaul S (1999) A canine model of chronic ischemic cardiomyopathy: characterization of regional flow-function relations. Am J Physiol 276:H446-H455
12. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Mercier JC, Corday E, Ganz W (1981) Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 101:593-600. doi: 10.1016/0002-8703(81)90226-X (Pubitemid 11120523)
13. Guth ND, Heusch G, Seitelberger R, Ross J Jr (1987) Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs. Circ Res 60:738-746. doi: 10.1161/01.RES.60.5.738 (Pubitemid 17098139)
14. Heusch G, Schulz R, Rahimtoola H (2005) Myocardial hibernation: a delicate balance. Am J Physiol Heart Circ Physiol 288:H984-H999. doi: 10.1152/ajpheart.01109.2004 (Pubitemid 40269997)
15. Heusch G (2013) The regional myocardial flow-function relationship: a framework for an understanding of acute ischemia, hibernation, stunning and coronary microembolization. Circ Res 112:1535-1537. doi: 10.1161/CIRCRESAHA.113. 301446
16. Heymann MA, Payne BD, Hoffman JI, Rudolph AM (1997) Blood flow measurements with radio-nuclide labeled particles. Prog Cardiovasc Dis 20:52-79. doi: 10.1016/S0033-0620(77)80005-4
17. Lalani I, Bhoi K, Ahmed AF (1979) Interleukin-10: biology, role in inflammation and autoimmunity. Ann Allergy 79:469-483. doi: 10.1016/S1081- 1206(10)63052-9
18. Le DE, Pelberg RA, Leong-Poi H, Bin JP, Linden J, Kaul S (2003) A1-receptor blockade: a novel approach for assessing myocardial viability in chronic ischemic cardiomyopathy. J Am Soc Echocardiogr 16:764-769. doi: 10.1016/S0894-7317(03)00214-1 (Pubitemid 37391032)
19. Le DE, Powers ER, Bin JP, Leong-Poi H, Goodman NC, Kaul S (2007) Transmyocardial revascularization ameliorates Ischemia by reversing paradoxical catecholamine-induced vasoconstriction. J Nucl Cardiol 14:207-214. doi: 10.1016/j.nuclcard.2006.12.328 (Pubitemid 46444678)
20. Li B, Liao YH, Cheng X, Ge H, Guo H, Wang M (2006) Effects of carvedilol on cardiac cytokines expression and remodeling in rat with acute myocardial infarction. Int J Cardiol 111:247-255. doi: 10.1016/j.ijcard.2005.08.065 (Pubitemid 44131484)
21. Libby P, Maroko PR, Covell JW, Malloch CI, Ross J Jr, Braunwald E (1973) Effect of practolol on the extent of myocardial ischaemic injury after experimental coronary occlusion and its effect on ventricular function in the normal and ischaemic heart. Cardiovasc Res 7:167-173. doi: 10.1093/cvr/7.2.167
22. Maack C, Elter T, Nickenig G, LaRosee K, Crivaro M, Stäblein A, Wuttke H, Böhm M (2001) Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure. J Am Coll Cardiol 38:939-946. doi: 10.1016/S0735-1097(01)01471-1 (Pubitemid 32912692)
23. Mann DL (2002) Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91:988-998. doi: 10.1161/01.RES.0000043825.01705.1B (Pubitemid 35416635)
24. Matsuzaki M, Patritti J, Tajimi T, Miller M, Kemper WS, Ross J (1984) Effects of beta-blockade on regional myocardial blood flow and function during exercise. Am J Physiol 247:H52-H60
25. McBride BF, White CM (2005) Critical differences among beta-adrenoreceptor antagonists in myocardial failure: debating the MERIT of COMET. J Clin Pharmacol 45:6-24. doi: 10.1177/0091270004269841
26. McTiernan CF, Lemster BH, Frye C, Brooks S, Combes A, Feldman AM, Charles F (1997) Interleukin-1β inhibits phospholamban gene expression in cultured cardiomyocytes. Circ Res 81:493-503. doi: 10.1161/01.RES.81.4.493 (Pubitemid 27432736)
27. MERIT-HF Study Group (1999) Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in-congestive heart failure (MERIT-HF). Lancet 353:2001-2007. doi: 10.1016/S0140-6736(99)04440-2 (Pubitemid 29271744)
28. Molenaar P, Christ T, Ravens U, Kaumann A (2006) Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart. Cardiovas Res 69:128-139. doi: 10.1016/j.cardiores.2005.08.024 (Pubitemid 41814817)
29. Moore K, Roberts LJ (1998) Measurement of lipid peroxidation. Free Radic Res 28:659-671. doi: 10.3109/10715769809065821 (Pubitemid 28454258)
30. Oh BH, Ono S, Gilpin E, Ross J (1993) Altered left ventricular remodeling with beta-adrenergic blockade and exercise after coronary reperfusion in rats. Circulation 87:608-616. doi: 10.1111/j.1540-8191.1996.tb00073.x (Pubitemid 23040931)
31. Okafor CC, Perreault-Micale C, Hajjar RJ, Lebeche D, Skiroman K, Jabbour G, Doye AA, Lee MX, Laste N, Gwathmey JK (2003) Chronic treatment with carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure. BMC Physiol 3:1-9. doi: 10.1186/1472-6793-3-6 (Pubitemid 38783232)
32. Oldroyd KG, Chopra M, Rankin AC, Belch JJF, Cobbe SM (1990) Lipid peroxidation during myocardial ischaemia induced by pacing. Br Heart J 63:88-92. doi: 10.1136/hrt.63.2.88 (Pubitemid 20053770)
33. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334:1349-1355. doi: 10.1056/NEJM199605233342101 (Pubitemid 26152713)
34. Pelberg RA, Spotnitz WD, Bin J-P, Le E, Goodman NC, Kaul S (2001) Mechanism of myocardial dysfunction in the presence of chronic coronary stenosis and normal resting myocardial blood flow: clinical implications. J Am Soc Echocardiogr 14:1047-1056. doi: 10.1067/mje.2001.113232 (Pubitemid 33095588)
35. Polidori MC, Savino K, Alunni G, Freddio M, Senin U, Sies H, Stahl W, Mecocci P (2002) Plasma lipophilic antioxidants and malondialhehyde in congestive heart failure patients: relationship to disease severity. Free Radic Biol Med 32:148-152 (Pubitemid 34127704)
36. Poole-Wilson PA, Swedberg K, Cleland JGF, Di Lenarda A, Hanrath P, Komajda M, Lubsen J, Lutiger B, Metra M, Remme WJ, Torp-Pedersen C, Scherhag A, Skene A, For the COMET Investigators (2003) Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol European trial (COMET): randomized controlled trial. Lancet 362:7-13. doi: 10.1016/S0140-6736(03)13800-7 (Pubitemid 36835815)
37. Prabhu SD, Chandrasekar B, Murray DR, Freeman GL (2000) β-Adrenergic blockade in developing Heart failure. Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 101:2103-2109. doi: 10.1161/01.CIR.101.17.2103 (Pubitemid 30233176)
38. Radovanovic S, Savic-Radojevic A, Pljesa-Ercegovac M, Djukic T, Suvakov S, Krotin M, Simic DY, Matic M, Radojicic Z, Pekmezovic T, Simic T (2012) Markers of oxidative damage and antioxidant enzyme activities as predictors of morbidity and mortality in patients with chronic heart failure. J Card Fail 18:493-501. doi: 10.1016/j.cardfail.2012.04.003
39. Rowland DG (1994) Gutgesell HP (1994) Use of mean arterial pressure for noninvasive determination of left ventricular end-systolic wall stress in infants and children. Amer J Cardiol 74:98-99 (Pubitemid 24196327)
40. Ruwald MH, Ruwald AH, Jons C, Alexis A, McNitts S, Zareba W, Moss AJ (2013) Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy. J Am Coll Cardiol 61:1518-1526
41. Siwik DA, Chang DL, Colucci WS (2000) Interleukin-1β and tumor necrosis factor-a decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 86:1259-1265. doi: 10.1161/01.RES.86.12.1259 (Pubitemid 30436667)
42. Sklenar J, Jayaweera AR, Kaul S (1992) A computer-aided approach for the quantification of regional left ventricular function using two-dimensional echocardiography. J Am Soc Echocardiogr 5:33-40
43. Yasunari K, Maeda K, Nakamura M, Yoshikawa J (2002) Carvedilol inhibits pressure-induced increase in oxidative stress in coronary smooth muscle cells. Hypertens Res 25:419-425 (Pubitemid 34752562)